# Nkarta (NKTX) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/NKTX
## Company Profile
- Ticker: NKTX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Oncology
## Stock Data
- Close: 2.2 USD
- Market cap: 208196991.78 USD
- Last updated: 2026-08-05
## Business Overview
### Allogeneic CAR-NK Company
Nkarta develops off-the-shelf natural killer cell therapies for autoimmune disease and cancer.
### NKX019
NKX019 is a CD19-directed CAR-NK therapy designed to deplete pathogenic B cells without patient-specific manufacturing.
### Ntrust Studies
Ntrust-1 and Ntrust-2 evaluate NKX019 across autoimmune diseases with outpatient dosing and the option for redosing.
## Why The Stock Is Moving

As of Aug 5, 2026, NKTX closed down 2.65% at $2.20. No new same-company headline was identified in the current news window.

## Future Catalysts

- Initial clinical data from Ntrust-1 and Ntrust-2 are planned for presentation at a medical meeting in 2026.

## Recent News
- 2026-05-12 20:01 EST — [Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights](https://biopharmsignal.com/news/NKTX/nkarta-reports-first-quarter-2026-financial-results-and-corporate-highlights) — Source: Nkarta
- 2026-04-15 20:01 EST — [Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers](https://biopharmsignal.com/news/NKTX/nkarta-announces-fda-agreement-on-outpatient-dosing-of-nkx019-in-autoimmune-disease-expanding-access-to-community-rheumatology-centers) — Source: Nkarta
- 2026-04-09 11:00 EST — [Nkarta to Participate in Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/NKTX/nkarta-to-participate-in-needham-virtual-healthcare-conference) — Source: Nkarta
- 2026-03-25 20:01 EST — [Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights](https://biopharmsignal.com/news/NKTX/nkarta-reports-fourth-quarter-and-full-year-2025-financial-results-and-corporate-highlights) — Source: Nkarta
- 2026-02-27 13:00 EST — [Nkarta to Participate in March Investor Conferences](https://biopharmsignal.com/news/NKTX/nkarta-to-participate-in-march-investor-conferences) — Source: Nkarta